In 1996, our Founders, in association with Mount Sinai Hospital, formed Canada's first cord blood bank: the Toronto Cord Blood Programme. In 2004, after many successes operating within Mount Sinai Hospital, the Toronto Cord Blood Programme chose to expand by partnering with Insception Biosciences to raise their cord blood offering to a new and higher level of excellence, all aimed at expanding the potential uses for cord blood samples in the treatment of diseases.
In 2012, Insception Lifebank acquired Lifebank Corporation, another successful Canadian cord blood bank company based in western Canada. The combined organization creates Canada’s largest, most experienced and financially stable FACT-accredited cord blood bank, providing greater stability and security for customers and ensuring best practices.
Led by a team of world-recognized research scientists and engineers with faculty positions at the University of Toronto, Insception Lifebank has developed technology in stem cell research and development to complement our cord blood banking service.
Insception Lifebank Cord Blood Program
Today, Insception Lifebank operates from a state-of-the-art facility in Mississauga, Ontario and is the largest cord blood program in Canada, with over 56,000 samples banked. By continuing to partner with leading Canadian medical facilities such as Toronto's Mount Sinai Hospital and The Scarborough Hospital, the Insception Lifebank Cord Blood Program is able to provide every family with the ability to collect and store their baby's valuable cord blood, while the company's Biosciences division focuses on developing new and improved applications for stem cells.
Insception Biosciences - Research and Development
Our objective is to continue to develop technologies that will improve the utility of cord blood stem cells by expanding the number of stem cells viable from the cord blood units.
In the past, Insception Biosciences enjoyed collaborative research partnerships with the following leading Canadian hospitals: Toronto's Mt. Sinai, Burlington's Joseph Brant Memorial Hospital and Muskoka Algonquin Hospital.
The primary nature of these relationships was the collection of the cord blood from parents wishing to donate their sample for research.
“Grounded in half a century of research, the study of hematopoietic stem cells is one of the most exciting and rapidly advancing disciplines in biomedicine today…Key issues for tapping the potential of hematopoietic stem cells will be finding ways to safely and efficiently expand the numbers of transplantable human HSCs in vitro or in vivo.”
Insception Lifebank's greatest capital is its human resources.
The leadership within the management and advisory levels at Insception Lifebank includes internationally-recognized researchers, scientists, physicians and senior level management executives with the collective experience to bring consistent and future value to the domestic and international cord blood banking community.
Insception Lifebank Cord Blood Program is dedicated to being an active member of the medical community. That's why we publish our semi-annual newsletter to inform patients and healthcare providers about the latest developments made by Insception Lifebank and the cord blood stem cell community at large. Read our newsletter for updates from patients who have undergone cord blood transplants, parents who have completed the cord blood banking process and researchers conducting studies on the applications of cord blood technology.